Cargando...
Ibrutinib in PCNSL: The Curious Cases of Clinical Responses and Aspergillosis
In this issue of Cancer Cell, Lionakis et al. demonstrate that the combination of temozolomide, etoposide, doxorubicin, dexamethasone, rituximab, and the Bruton tyrosine kinase (BTK) inhibitor ibrutinib induced frequent responses in patients with primary central nervous system lymphoma but was assoc...
Gardado en:
| Publicado en: | Cancer Cell |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5572136/ https://ncbi.nlm.nih.gov/pubmed/28552326 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ccell.2017.05.004 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|